Market Overview

Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market, 2018-2025 - Trials Likely to Contribute to the Growth of the Market - ResearchAndMarkets.com

Share:

The "Transcatheter
Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Size, Share &
Trends Analysis Report By Procedure (Transapical, Transfemoral,
Transaortic), By Country, Vendor Landscape, And Segment Forecasts, 2018
- 2025"
report has been added to ResearchAndMarkets.com's
offering.

The global transcatheter aortic valve replacement (TAVR) devices market
size is anticipated to reach USD 12.2 billion by 2025, progressing at a
CAGR of 22.6% during the forecast period.

Increasing incidence of cardiovascular diseases and severe aortic
stenosis disorder are among key factors augmenting the TAVR device
market. Moreover, rising number of various clinical trials such as
Edwards SAPIEN 3 and Medtronic Transcatheter Aortic Valve 2.0
Replacement System are likely to contribute to the growth of the market
during the forecast period.

Improvements in surgical techniques and quality of implantable valves
are leading to an increase in the adoption of aortic valve replacement
procedures. Moreover, surging demand for minimally invasive surgeries as
compared to traditional open heart procedures, availability of
reimbursement for surgical procedures, and growing inclination of
physicians towards TAVR procedures are projected to boost the growth of
the market.

Launch of new devices with advanced technology for fast and effective
treatment is poised to propel the market. For instance, in April 2016,
St. Jude Medical launched a new device - Trifecta Valve with glide
technology to be used in both conventional as well as minimally invasive
procedures.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Market Definitions

Chapter 3 Research Methodology

Chapter 4 Market Variables, Trends & Scope

Chapter 5 Regulatory Framework

Chapter 6 Transcatheter Aortic Valve Replacement (TAVR) Market: By
Procedure Estimates & Trend Analysis

Chapter 7 Transcatheter Aortic Valve Replacement (TAVR) Market: By
Device Estimates & Trend Analysis

Chapter 8 Transcatheter Aortic Valve Replacement (TAVR) Market: Regional
Estimates & Trend Analysis

Chapter 9 Competitive Landscape

  • Medtronic plc
  • Boston Scientific Corporation
  • Meril Life Sciences Pvt. Ltd., Inc.
  • Edwards Lifesciences Corporation
  • St. Jude Medical, Inc.
  • JenaValve Technology, Inc.
  • Bracco SpA
  • Transcatheter Technologies GmbH
  • Abbott

For more information about this report visit https://www.researchandmarkets.com/research/bb37gt/global?w=4

View Comments and Join the Discussion!